Latest Research Trends (23 March 2026)

Advancing Neoadjuvant Therapy Testing with Patient-Derived Breast Cancer Models

Journal: Science Translational Medicine

Author: Stefan J. Hutten et al.

Revolutionary patient-derived organoid study classifies oral cancers into three morphological subtypes (normal-like, dense, and grape-like), correlating with genomic profiles and patient outcomes, potentially transforming treatment approaches for this aggressive disease.

Targeting Small Cell Lung Cancer Through Subtype-Specific Vulnerabilities

Journal: Science Translational Medicine

Author: Amanda Luvisotto et al.

Small cell lung cancer (SCLC) is a highly aggressive and heterogeneous disease driven by distinct molecular subtypes defined by key transcription factors, each with unique therapeutic dependencies and resistance mechanisms. Understanding these subtype-specific pathways – along with tumor plasticity and epigenetic regulation – reveals new opportunities for personalized and more durable treatments, including targeted and epigenetic-based strategies.

A Human-Specific Enhancer Drives Brain Expansion via Chromatin Architecture

Journal: Cell Stem Cell

Author: Mosti F, Liu J, Lam K et al.

A human-specific enhancer, HAR1984, promotes neurogenesis and cortical expansion by regulating gene expression through species-specific chromatin interactions, as shown in organoids and mouse models. It enhances expression of key genes like ETV5 and TRA2B via chromatin looping and a positive feedback mechanism, revealing how genetic changes contribute to human brain evolution.

Tumours Exploit Extracellular Glutathione as a Cysteine Source

Journal: Nature

Author: Hecht, F., Zocchi, M., Tuttle, E.T. et al.

Tumours rely on extracellular glutathione (GSH) as a reservoir of amino acids, particularly cysteine, to sustain growth under nutrient-limited conditions. Blocking GSH breakdown via γ-glutamyltransferase inhibition reduces cysteine availability and slows tumour progression, revealing a new therapeutic strategy targeting tumour metabolism.

Subscribe to the latest updates in the newsletter

Share your disease area, therapeutic candidate and research objectives.

Related Solutions

Organoid Service

Research Service

Technical Service

ODISEI CNS - Human brain & retinal organoid
solutions for translational CNS discovery.

Please provide the information below, and our team will contact you shortly with brochure and relevant case studies.

Thank you for your submission.

Our team has received your request and will get back to you shortly.
If you do not receive our confirmation email, kindly check your spam or junk folder.